Bringing New Ideas to AAV Gene Therapy
By Erik Wiklund
November 20, 2025
As safety concerns and commercial doubts threaten the AAV gene therapy field, new technologies may offer a “well-rounded” solution.
3 min read
False
By Erik Wiklund
November 20, 2025
As safety concerns and commercial doubts threaten the AAV gene therapy field, new technologies may offer a “well-rounded” solution.
3 min read
November 11, 2025
Drug manufacturing is under pressure as biologics become more complex. To simplify progress, cell line development is evolving with AI and automation.
7 min read
November 3, 2025
For advanced therapies, every hour counts. The pressure on QA and QC teams is intense. How can automation ease the strain?
4 min read
October 29, 2025
Manual processes in cell therapy manufacturing are unsustainable. Bring in the robots.
3 min read
October 27, 2025
By focusing on functional activity, Abalone Bio is advancing CB2-targeting antibodies with the potential to transform treatment for fibrosis, neuropathy, and beyond.
6 min read
October 24, 2025
How biology, sustainability, and a nod to the African pygmy hedgehog are reshaping how we move living cells around the world – and beyond.
6 min read
October 21, 2025
Cellares CEO Fabian Gerlinghaus talks about automation, partnerships, and inspiration from Carl June.
3 min read
October 17, 2025
What will it take to make decentralized CAR-T manufacturing work in the real world? Three experts discuss in this roundtable.
7 min read
October 15, 2025
With remarkable successes come inevitable hurdles. Find out what experts had to say about GLP-1 drug development during an AAPS workshop.
8 min read
By Jo Varshney
October 14, 2025
AI is fast tracking new therapies, but speed means nothing if we can't trust the systems.
4 min read
False
False
False